In Brief: Boston Scientific/CorTrak
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific/CorTrak: Boston Scientific gains exclusive international distribution rights to CorTrak's coronary iontophoresis drug delivery technology. CorTrak's technology, currently in clinical trials, will initially be used for treating and/or preventing angioplasty associated complications. The system "uses a catheter and an electronic field to transport drugs through difficult tissue barriers and into the cells...more quickly and deeply than conventional drug delivery systems," CorTrak says...